iollo Analysis
What is iollo?
iollo specializes in measuring over 500 advanced blood biomarkers to provide personalized health insights. Their unique approach combines cutting-edge technology with scientific research to deliver comprehensive health reports. This enables users to make informed decisions about their health, nutrition, and lifestyle.
Location
2261 Market Street, San Francisco, California, United States
Employees
1-10
Founded
2021
Revenue
$750K
Audit Date
2025-10-24
Audit Staleness
3-6 months stale
Audit Type
SOC 2 Type 2
Business Model
Subscription-based model with potential partnerships for revenue generation.
Funding Status
Seed
Infra Provider
AWS
Product Features & Capabilities
- Measure 500+ advanced biomarkers, personalized health insights, biological age assessment, metabolic health evaluation, heart health monitoring, gut microbiome analysis, home sample collection, personalized reports and recommendations, regular health engagement, HSA/FSA accepted.
Pricing
- Essential Plan: From $299 per test
- Expanded Plan: From $399 per test
- Comprehensive Plan: From $459 per test
Who are the founders of iollo
DG
Daniel Gomari
Founder/CEO
Investors
- Goodwater Capital
- Y Combinator
- Palrecha Capital
- Fundament
- Hummingbird Ventures
Market Focus
iollo primarily focuses on the health and wellness industry, specifically in advanced health testing and personalized health insights through biomarker analysis.
Competitors Overview
iollo operates in the advanced health testing market, focusing on measuring over 500 biomarkers from a single blood sample to provide personalized health insights. Its main competitors include:
- Labcorp: A leader in laboratory testing, Labcorp offers a wide range of diagnostic services, inclu
See something that needs updating? Suggest edits to this profile.